DISCO Pharmaceuticals raises €36M A round with NRW.BANK, Ackermans & van Haaren, Sofinnova Partners, AbbVie Ventures, M Ventures, and Panakes Partners.

Biotech Health services Pharma

Germany

United States

Netherlands

Italy

France

Belgium

Investments

02 December 2025

Share:

Disco Pharmaceuticals (company)

Germany

Biotech Health services Pharma

Total investments received (USD): 63.42m

Round value (USD): 41.62m

Round investors: AbbVie Ventures Merck Ventures NRW.BANK Panakès Partners Sofinnova Partners Ackermans & van Haaren

Company: Disco Pharmaceuticals

Industry: Biotech Health services Pharma

Related deals

T-curx raised €17.7m in Series A funding led by BiomedVC, joined by investors including Bayern Kapital, HighLight Capital and i&i Bio Fund.

Biotech Health services Manufacturing Pharma

Germany

Switzerland

Luxembourg

Japan

Investments 03 December 2025

Captain T Cell in a €20M series A led by Springboard Health and Pluton Asset, joined by Sintra, TGFS, i&i Biotech Fund, HIL-INVENT and Brandenburg Kapital.

Biotech Health services

Germany

Austria

Luxembourg

Switzerland

United Kingdom

Investments 02 November 2025

Tubulis in a €36m Series C extension funding (round total now €344m) with new backers are Fidelity, Janus Henderson, and Blackstone.

Biotech Health services

Germany

United States

Investments 22 October 2025

AMSilk raised €22m in debt and €30m in post series C equity funding led by Athos, joined by insiders MIG Capital and Novo Holdings.

Biotech Health services Manufacturing

Germany

Denmark

Investments 01 September 2025